To test if this inhibition of CTL infiltration by IL-17 happens in early stage CRC, we performed flow cytometry analysis on tumors that developed following tamoxifen-induced deletion of Apc in colonic epithelium. This evidence concerns the gene IL17A and colorectal carcinoma.